Position in CRSP
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,376,307
+$1,143,670 QoQ
Shares Held
153,581
+1.0% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 521 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Derivatives in CRSP
reported options exposure · as of Sep 30, 2025CallValue
$375,898
CallShares
5,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. CRSP ranks #19 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in CRSP
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,376,307 | 153,581 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $7,232,637 | 152,042 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $8,958,377 | 170,831 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $375,898 | 5,800 | Call | Sole | 2025-11-12 | |
| 2025-09-30 | $13,678,863 | 211,061 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,464,322 | 194,579 | Shares | Sole | 2025-08-12 | |
| 2025-06-30 | $321,024 | 6,600 | Call | Sole | 2025-08-12 | |
| 2025-03-31 | $6,311,135 | 185,458 | Shares | Sole | 2025-05-07 | |
| 2025-03-31 | $221,195 | 6,500 | Call | Sole | 2025-05-07 | |
| 2024-12-31 | $5,893,215 | 149,726 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,050,068 | 107,494 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,270,074 | 116,091 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $7,219,507 | 105,920 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,788,058 | 92,461 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,121,366 | 90,799 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,094,873 | 90,753 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,695,878 | 81,713 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,166,025 | 77,885 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,107,690 | 78,159 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,376,594 | 72,019 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,103,400 | 65,372 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,950,562 | 52,132 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,202,936 | 55,418 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,034,600 | 49,630 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,642,386 | 46,306 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,655,614 | 56,532 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,068,918 | 36,692 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,213,034 | 57,328 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $941,374 | 22,197 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||